Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo

Published:2013-12 Issue:3 Volume:149 Page:450-463
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Horwitz David A.,Pan Stephanie,Ou Jing-Ni,Wang Julie,Chen Maogen,Gray J. Dixon,Zheng Song Guo

Funder

National Institutes of Health

Arthritis Foundation

Southern California Chapter

Athelos-Neostem Inc.

Treadwell Foundation

Schwab Charitable Trust

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference66 articles.

1. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion;Miyara;J. Allergy Clin. Immunol.,2009

2. Treating human autoimmunity: current practice and future prospects;Rosenblum;Sci. Transl. Med.,2012

3. Loss of FOXP3 expression in natural human CD4+ CD25+ regulatory T cells upon repetitive in vitro stimulation;Hoffmann;Eur. J. Immunol.,2009

4. Relative resistance of human CD4(+) memory T cells to suppression by CD4(+) CD25(+) regulatory T cells;Afzali;Am. J. Transplant.,2011

5. Allograft rejection mediated by memory T cells is resistant to regulation;Yang;Proc. Natl. Acad. Sci. U. S. A.,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen;Frontiers in Immunology;2024-07-26

2. Single cell analysis of human CD8⁺T cells reveals CD45RC^low/-TNFR2⁺CD29^lowCD8⁺Tregs with superior activity;2023-12-14

3. The TNFα/TNFR2 axis mediates natural killer cell proliferation by promoting aerobic glycolysis;Cellular & Molecular Immunology;2023-08-09

4. TNFα/TNFR2 axis mediates natural killer cell proliferation by enhancing their glycolytic plasticity;2022-12-15

5. Efficacy of low-dose hCG on FET cycle in patients with recurrent implantation failure;Frontiers in Endocrinology;2022-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3